Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World Practice

Data regarding chemotherapy options and benefits in older women with early triple-negative breast cancer (TNBC) are limited. Our study aimed to assess the effects of adjuvant chemotherapy on recurrence-free survival (RFS), breast cancer-specific survival (BCSS), and overall survival (OS) rates in el...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Meng Xiu, Pin Zhang, Qing Li, Peng Yuan, Jiayu Wang, Yang Luo, Fei Ma, Ruigang Cai, Ying Fan, Qiao Li, Binghe Xu
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2022-04-01
Col·lecció:Frontiers in Oncology
Matèries:
older women
triple-negative breast cancer
chemotherapy
recurrence
survival
Accés en línia:https://www.frontiersin.org/articles/10.3389/fonc.2022.867583/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars